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We  studied  the  association  between  intake  of non-prescription  analgesics  and  semen  quality  and  male
reproductive  hormone  levels  in  a cross-sectional  study  among  1493  men.  The  men  provided  one  semen
(n = 1493)  and  blood  sample  (n  = 1056)  and  ﬁlled  in  questionnaires  on use  of  non-prescription  analgesics
(paracetamol,  NSAIDs  and  combination  drugs  (yes/no)).  Adjusting  for  age,  study  and other  covariates,  we
observed  no  association  between  intake  of  non-prescription  analgesics  and  markers  of semen  quality.
Adjusting  for  age  and  time  of  day  of blood  sampling,  users  of  non-prescription  analgesics  had a 10.4%  (95%aracetamol
on-steroidal anti-inﬂammatory drugs
eproductive health
emen analysis
onadal steroid hormones
conﬁdence  interval  (CI) 4.0–17.1%)  higher  testosterone  level  than  non-users.  When  we  stratiﬁed  by  med-
ication type,  the  association  between  analgesics  and higher  testosterone  was  observed  between  users  of
non-steroidal  anti-inﬂammatory  drugs  (NSAIDs)  and  combination  drugs  but  not  paracetamol.  This  study
suggests  that  use  of  non-prescription  analgesics  is  associated  with  slightly  higher  serum  testosterone
levels  than  non-use.
©  2017  The  Authors.  Published  by  Elsevier  Inc.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
About 15% of couples trying to conceive do not achieve a preg-
ancy within one year of unprotected intercourse [1]. Various
iseases affect human fertility negatively, but no single cause has
een identiﬁed to account for the present fecundity problems,
lthough reduced semen quality is a concern.
A considerable proportion of the general population uses
on-prescription medication such as paracetamol (also known
s acetaminophen) and non-steroidal anti-inﬂammatory drugs
NSAIDs); and sales of these non-prescription analgesics have
ncreased during the past 20 years [2]. Although paracetamol and
SAIDs are used in substantial quantities throughout the world,
he mechanisms by which they act are only partly known. Both
ompounds are thought to act through cyclo-oxygenase (COX) inhi-
ition which results in inhibition of the prostaglandin synthesis
3]; and this inhibition of prostaglandins is suggested to disturb
he masculinization in the prenatal period in mice [4]. However,
aracetamol may  also act as a cannabinoid (CB1) activator [5].
∗ Corresponding author at: Department of Occupational and Environmental
edicine, Bispebjerg-Frederiksberg University Hospital, Bispebjerg Bakke 23, DK-
400 Copenhagen NW,  Denmark.
E-mail address: Birgit.hoeyer@regionh.dk (B.B. Høyer).
ttp://dx.doi.org/10.1016/j.reprotox.2017.09.004
890-6238/© 2017 The Authors. Published by Elsevier Inc. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
An animal study found reduced anogenital distance in male
rats prenatally exposed to paracetamol and acetylsalicylic acid [6],
which could indicate either anti-androgen or oestrogen effects.
Paracetamol has furthermore been related to suppressed testos-
terone production in mice [7].
In humans, lower sperm motility has been reported in relation
to acetylsalicylic acid use [8], and regular use of traditional NSAIDs
such as ibuprofen, has been associated with reduced semen quality
in a group of patients attending the Andrology and Reproduction
Laboratory in Córboda, Argentina [9]. However, as these men  suffer
from illness, we cannot exclude the risk of confounding by indica-
tion.
Another study reported no overall association between expo-
sure to NSAIDs and reproductive hormones however lower levels
of oestrogens, testosterone and dihydroepiandrosterone were
observed in the subgroup of users of NSAIDs, who  also were over-
weight and physically inactive [10].
The wide exposure through self-medication in the general pop-
ulation and the risk that these non-prescription analgesics may
affect human hormones make these drugs potential disturbers of
the human endocrine control of the reproductive function. Further-
more, tests of adverse effects on reproductive function are not part
of the routine test of new medicines, and therefore the potential
effects of medication on fertility is unknown for the vast majority
of products and call for studies with information of medicine use
and male reproductive function.
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table  1
Number of participants, participation rates and year of study in the three cohorts.
Study subgroups Number of Participantsa Participation rateb (%) Year of study Reference
Lead workers 437 18 1996–1997 Bonde et al. [11]
Farmers 256 32 1995–1996 Larsen et al. [12]
Inuendo 800 18 2002–2004 Toft et al. [13]
Total 1493
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(a Number of participants with information on medicine use and markers of repro
b Participation rate in the original studies.
Our study is to date the largest epidemiological study to exam-
ne the association between intake of paracetamol and NSAIDs and
emen quality and male reproductive hormones in Greenlandic and
uropean men.
. Methods
.1. Study population
From 1995 to 2004, three separate occupational or environmen-
al semen quality studies were conducted by our research group
nd collaborators. A total of 1493 men  participated (Table 1). One
tudy included lead workers from England, Belgium and Italy (the
ead worker study) [11], one comprised Danish farmers (the Farmer
tudy) [12] and one comprised men  from the general population in
reenland, Poland, Sweden and Ukraine (the Inuendo study) [13].
The Lead worker and the Farmer studies were both occupational
tudies investigating semen quality in relation to inorganic lead and
esticides, respectively. The Inuendo study was  an environmen-
al study investigating semen quality in relation to environmental
rganochlorine exposure.
The men  were included in the studies if they had: No vasectomy,
o known azoospermia and reproductive organ abnormalities. The
articipation rates varied from 18 to 32%.
The study population in the present study comprises the 1493
en  with information on intake of non-prescription medication
nd markers of semen quality. Only the Farmer and Inuendo stud-
es had information on reproductive hormones (n = 1056). Detailed
tudy descriptions are found in the original publications and
haracteristics according to original study is presented in Supple-
entary Table 1.
.2. Ethical approvals
Ethical approval was obtained for all included studies by local
thical authorities.
.3. Measures of exposure
Information on use of non-prescription analgesics was  obtained
rom self-completed questionnaires. In the Lead worker and Farmer
tudies, the men  were asked about any use of medication during the
ast three months and in the Inuendo study, the men  were asked
bout any medicine use during the past six months. Furthermore,
articipants were asked to specify the medicine name, if any use.
nformation on dose and duration of use was not reported.
We pooled all analgesics into one group for the main analy-
is (yes/no) and also stratiﬁed it in three sub-groups: paracetamol
yes/no), NSAIDs (including acetylsalicylic acid) (yes/no) and com-
ination drugs (drugs containing a mixture of analgesics and
ther medications (e.g. paracetamol, NSAIDs and antihistamines))
yes/no).ve health.
2.4. Measures of outcome
The participants produced a semen sample by masturbating into
a 50 ml  polyethylene jar. The samples were collected at the partic-
ipants’ homes and kept close to the body during transportation to
avoid cooling. Semen analysis was performed either in a mobile
laboratory or in a hospital laboratory, and 82.3% of the samples
were analysed within the ﬁrst hour after ejaculation. Trained med-
ical laboratory technicians performed the analyses in accordance
with the successive editions of the guidelines published by the
World Health Organization (1980–1999) in its Laboratory manual
for examination of human semen and sperm – cervical mucus inter-
action [14,15]. Semen volume was  measured in a tube with 0.1 ml
accuracy or on a balance. Sperm concentration was  counted in an
improved Neubauer chamber by use of a phase-contrast micro-
scope.
Among the participants in the Farmer and Inuendo studies,
blood samples were collected by trained medical laboratory tech-
nicians. No blood samples were collected in the Lead study. Serum
was stored at −20 or −80◦ C until analysis.
In the Farmer study, all hormones were analysed using immuno-
metric methods, as earlier described [12]. The lower limits of
detection (LOD) of luteinizing hormone (LH), follicle stimulating
hormone (FSH) and sex hormone binding globulin (SHBG) assays
were 0.05 IU/l, 0.06 IU/l and 0.5 nmol/l, respectively. The coefﬁ-
cients of variation (CV) within and between assays were <10%. The
LOD of the testosterone assay was 0.23 nmol/l, and the CV within
and between assays were <10%. The LOD for Inhibin B was  0.20 ng/l
and the CV within and between assays were <12% and <17%, respec-
tively.
In the Inuendo study, all assays were analysed at Skåne Uni-
versity Hospital (Malmö, Sweden), as earlier described in [16]. The
LODs were 0.2 IU/l for LH, 0.2 IU/l for FSH and 8.0 pmol/l for estra-
diol. The CVs were 2.9%, 2.6% and 8.1%, respectively. The LOD for
serum testosterone was 0.35 nmol/l and CV of 2.8% at 2.9 nmol/l
and 3.2% at 8.1 nmol/l. The LOD for SHBG was 0.02 nmol/l and the
CVs were 5.5% and 4.6%, respectively. The LOD for Inhibin B was
15 ng/l and intra-assay and total assay CV <7%.
2.5. Covariate data
Information on potential confounding factors, including
lifestyle, occupational, reproductive and medical information was
obtained from the main questionnaires used in the original studies.
Information on sexual abstinence and spillage during semen collec-
tion was collected from a questionnaire ﬁlled in by the participants
when delivering the semen sample.
2.6. Statistical analyses
The exposure variables non-prescription analgesics, paraceta-
mol, NSAIDs and combination drugs were dichotomized (yes/no).
The outcome variables sperm concentration, semen volume, total
sperm count, percentage motile sperm cells (motility), percentage
morphologically normal sperm cells (morphology), DNA fragmen-
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ation index (DFI), LH, FSH, Inhibin B, SHBG, testosterone and
stradiol were continuous. We  evaluated the model ﬁt by visual
nspection of residuals versus predicted values. To improve nor-
ality and homogeneity of variance of the residuals in the tested
ssociations, all outcomes were ln-transformed. Generalized mul-
iple linear regression analysis was used to assess the associations
etween use of analgesic and the markers of semen quality and
eproductive hormones. The main results are pooled analysis of all
hree study populations. The results from the multiple regression
nalyses were back-transformed and are presented as percentage
ifferences with 95% conﬁdence intervals (CI) on the original scale.
The multivariate semen models all included age (continuous),
nd disease in the reproductive organs (including: chlamydia infec-
ion, gonorrhea, syphilis, cryptorchidism, epididymitis, mumps  in
dulthood, orchitis, testicular cyst, testicular cancer and surgery
ecause of varicocele) (yes/no), fever during the past three months
yes/no) and sexual abstinence time (continuous, days). Sperm con-
entration, motility and morphology were additionally adjusted
or spillage during collection of the semen sample (yes/no). More-
ver, analysis of motility only included samples analysed within
ne hour of collection, and total sperm count and semen volume
nly included samples from individuals reporting no spillage. In
nalyses of sperm concentration and total sperm count, only sam-
les >0 were included in the models since all exposures were
n-transformed. All pooled models were in addition adjusted for
ub-study (categorical).
In the hormone models, age (continuous) and time of the day for
ampling (before or after 12 a.m.) were entered as covariates, and
ll the pooled models were adjusted for sub-study (categorical).
We  evaluated potential effect modiﬁcation of the associa-
ion between the exposures and outcomes by study sub-group
sing stratiﬁed analysis and by adding interaction terms in the
odels (e.g. Farmer sub-study*non-prescription analgesics). In
upplementary analyses, the exposure-outcome associations are
resented stratiﬁed by medicine type (paracetamol, NSAIDs and
ombination drugs). As a sensitivity analysis, the excluded 0 values
n sperm concentration (n = 2) and total sperm count (n = 2) were
dded with 0.5 and motility (n = 2) to keep them in the analyses.
All statistical analyses were performed using STATA 13.1 (Stat-
Corp, College Station, TX, USA).
. Results
.1. Characteristics of the study population
Characteristics of the 1493 participants stratiﬁed by intake of
on-prescription analgesics are presented in Table 2. Compared to
on-users (n = 1236) of non-prescription analgesics, users (n = 257)
ere slightly younger, more often smokers and reported having
ad fever during the past three months. Furthermore, users less
ften suffered from diseases in the reproductive organs, and had
 shorter time to analysis. The duration of sexual abstinence was
 days among both users and non-users of non-prescription anal-
esics. Of the participants using non-prescription analgesics, 27.3%
sed paracetamol, 50.3% used NSAIDs and 22.5 used combination
rugs (Table 2).
.2. Non-prescription analgesics and markers of semen quality
nd male reproductive hormones
Unadjusted and adjusted percentage difference of the semen
uality and sex hormones in relation to intake of non-prescription
nalgesics are presented in Tables 3 and 4, respectively. We  found
o associations between analgesics and semen quality in neither
ooled nor stratiﬁed (by sub-study) analyses (Table 3).xicology 74 (2017) 70–76
In pooled analysis, intake of non-prescription analgesics
was positively associated with testosterone (adjusted difference
(CI) = 10.4% (4.0, 17.1) and also among men  from the Inuendo study
(adjusted difference (CI) = 12.3% (4.5, 20.7)), but apparently not
in the Farmer study (adjusted difference (CI) = 3.7% (−7.0, 15.4))
(Table 4). No signiﬁcant effect modiﬁcation by sub-study was  indi-
cated except for SHBG with an interaction p = 0.04.
Results stratiﬁed by type of medication are presented in Sup-
plementary Tables 2–7. No associations were seen between intake
of paracetamol (Supplementary Table 2), NSAIDs (Supplementary
Table 3) or combination drugs (Supplementary Table 4) and mark-
ers of semen quality. No association was  present between intake
of paracetamol and male reproductive hormones (Supplementary
Table 5). In the pooled analyses of intake of NSAIDs and male repro-
ductive hormones, testosterone tended to be higher among men
using NSAIDs (adjusted difference (CI) 8.3% (−0.3, 17.7)) (Supple-
mentary Table 6). When stratiﬁed by sub-study, the estimates were
similar but CIs wider. Use of NSAIDs was associated with lower
Inhibin B among men  from the Inuendo study which was not con-
sistent through the studies. In the pooled analyses of intake of
combination drugs and male reproductive hormones, testosterone
was higher among men  using combination drugs (adjusted differ-
ence (CI) 13.4% (2.5, 25.5)) (Supplementary Table 7).
4. Discussion
In the present study of 1056 men  with measured hormone lev-
els, we observed a slightly higher serum testosterone level among
users of non-prescription analgesics. The association seemed to be
driven mainly through intake of NSAIDs and combination drugs.
No associations between intake of non-prescription analgesics and
markers of semen quality were observed in the 1493 men with
measured semen quality markers.
To our knowledge, only two prior studies have reported on
the association between intake of non-prescription analgesics
and markers of semen quality. Among 34 young men, who
used ≥500 mg  of acetylsalicylic acid per week, signiﬁcantly lower
sperm motility was reported as compared to non-use [8]. Authors
reported adjustment for alcohol consumption and tobacco smok-
ing but no other possible confounders were considered including
time from ejaculation to analysis. Corresponding to the ﬁndings by
Stutz and colleagues, lower sperm motility was reported in relation
to intake of NSAIDs along with lower seminal volume, percentage
morphological normal spermatozoa and glucosidase concentration
and higher percentage of dead cells in a sample of 1376 patients
attending the Andrology and Reproduction Laboratory in Argentina
[9].
In a study of 1766 men  from the Boston Area Community Health
Survey (2002–2005), no overall difference in hormone level in rela-
tion to NSAID use was  observed. However, when stratiﬁed by BMI
and activity level NSAID use was  associated with lower testosterone
and estradiol levels in obese men  and lower testosterone and dehy-
droepiandrosterone sulfate levels in inactive men [10]. We  could
not test these results as the number of obese men in our study was
low (n = 73), and we had no information on activity level. Among
the normal weight men  in our study, we  still observed a positive
association between intake of NSAIDs and combination drugs and
higher testosterone levels (data not shown). In another study of
18 young men, authors observed no association between intake of
acetylsalicylic acid and serum testosterone [8]. Similarly, among 12
moderately trained athletes, no association was observed between
intake of acetylsalicylic acid and serum testosterone, albeit acetyl-
salicylic acid modiﬁed the absolute and percentage of variation of
testosterone and cortisol and their ratio compared to placebo [17].
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Table  2
Characteristics of the study population.
Non-users of non-prescription analgesics N = 1236 Users of non-prescription analgesics N = 257
Person related characteristics:
Age (years) 36.1
(9.3)
34.2
(8.9)Mean (SD)
Body Mass Index (kg/m2)a 25.8
(3.5)
25.3
(3.5)Mean (SD)
Smoking (yes) 571
(46.2)
156
(60.7)Number (%)
Diseases in reproductive organs 264
(21.4)
44
(17.0)Number (%)
Fever during past three months (>38 ◦C) 98
(7.9)
36
(14.0)Number (%)
Semen related characteristics:
Sperm concentration (106/ml) 54.4
(8.0–195.0)
52.0
(10.0–183.3)Median (5th-95th percentile)
Semen volume (ml) 3.0
(1.0–6.6)
3.0
(1.3–7.0)Median (5th-95th percentile)
Total count (x106) 161.5
(15.6–706.9)
165.2
(20.4–630.0)Median (5th-95th percentile)
Motile sperm (%) 56.0
(19.0–82.0)
58.0
(21.0–84.0)Median (5th-95th percentile)
DFI (%) 10.8
(4.1–36.1)
11.7
(3.8–33.6)Median (5th-95th percentile)
Spillage at sampling 150
(12.1)
26
(10.1)Number (%)
Time to analysis (minutes) 45
(25–90)
35
(25–90)Median (5th-95th percentile)
Duration of abstinence (days) 3
(1–10)
3
(1–7)Median (5th-95th percentile)
Hormone related characteristics
Luteinizing hormone (IU/l) 3.8
(1.9–7.9)
3.8
(1.8–8.0)Median (5th-95th percentile)
Follicle stimulating hormone (IU/l) 4.0
(1.7–9.9)
4.1
(1.7–11.7)Median (5th-95th percentile)
Inhibin B (pg/ml) 179.0
(90.0–313.0)
176.0(77.0–314.0)
Median (5th-95th percentile)
Sex hormone binding globulin (nmol/l) 29.5
(14.5–57.7)
29.9
(15.8–49.1)Median (5th-95th percentile)
Testosterone (nmol/ml) 14.3
(7.4–24.1)
16.2
(8.4–26.0)Median (5th-95th percentile)
Estradiol (pmol/l) 67.8
(41.0–112.6)
72.4
(48.7–117.0)Median (5th-95th percentile)
Use of analgesics:
Paracetamol – 70
(27.3)Number (%)
NSAIDs – 129
(50.2)Number (%)
Combinationb – 58
(22.5)Number (%)
Cohorts:
Lead workers 364
(83.3)
73
(16.7)Number (%)
Farmers 212
(82.5)
44
(17.1)Number (%)
Inuendo 660 140
Drugs
B
a
u
f
a
a
h
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b
t(82.5)Number (%)
a Among non-users, 8.6% had missing BMI; among users, 9.7% had missing BMI. b
oth aforementioned studies are limited by the small sample size,
nd thus, the risk of type 2 error cannot be eliminated.
Our ﬁndings concerning elevated testosterone levels among
sers of NSAIDs and combination drugs correspond with results
rom an experimental study using fetal testes tissue from induced
bortions. The authors reported indomethacin and acetylsalicylic
cid exposure to be associated with higher testosterone levels in
uman ex-vivo gestational week 8–12 fetuses. Corresponding to
ur results, they observed no association between fetal paraceta-
ol  exposure and testosterone levels [18].
Others ﬁnd oppositely that non-prescription analgesics tend to
e associated with reduced testosterone levels both in experimen-
al and human studies. Hence, direct exposure to paracetamol and(17.5)
 with several pharmaceuticals combined.
indomethacin decreased testosterone production in adult human
testes explants [19], and intake of paracetamol and acetylsalicylic
acid reduced testosterone production in ex-vivo fetal rat testes [6].
Furthermore, testosterone production was  inhibited by paraceta-
mol, acetylsalicylic acid and indomethacin in an ex-vivo model
on gestational day 14.5 rat testes [20]. Finally, van den Driesche
and colleagues reported seven days exposure of paracetamol to be
associated with reduced plasma testosterone in castrate host mice
bearing human fetal testis xenografts, whereas exposure for one
day showed no association [7]. This could indicate that duration of
exposure is relevant as could be expected.
The mechanism by which NSAIDs could cause higher testos-
terone levels is not well established. The prostaglandin inhibition
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Table 3
Markers of semen quality regressed on use of non-prescription analgesics among men  from three cohorts.
Cohort Outcome Exposed/N Crude  (95% CI) Adjusted  (95% CI)a Interaction pb
Pooledc
Sperm conc (106/ml) 252/1465 −1.4 (−13.6, 12.6) −0.6 (−13.1, 13.7) 0.13
Semen volume (ml) 229/1291 −0.50 (−8.0, 7.6) −0.53 (−8.0, 7.6) 0.58
Total  count (x106) 226/1279 1.9 (−12.9, 19.3) 2.3 (−12.8, 20.0) 0.20
Motile sperm (%) 177/1045 3.1 (−4.5, 11.4) 3.5 (−4.4, 12.0) 0.64
Normal cells (%)d – – – –
DFI  (%) 232/1333 1.0 (−7.9, 10.7) 3.4 (−5.5, 13.1) 0.35
Lead  workers
Sperm conc (106/ml) 70/418 20.0 (−8.6, 57.5) 23.5 (−6.3, 62.9) –
Semen volume (ml) 67/372 5.0 (−10.3, 22.9) 1.8 (−12.7, 18.7) –
Total  count (x106) 66/367 23.4 (−8.9, 67.1) 23.4 (−9.3, 68.0) –
Motile sperm (%) 24/192 14.6 (−3.3, 35.8) 13.5 (−4.6, 34.9) –
Normal cells (%)d – – – –
DFI  (%) 57/353 12.2 (−6.7, 35.0) 11.8 (−6.3, 33.4) –
Farmers
Sperm conc (106/ml) 44/254 −10.7 (−34.9, 22.6) −6.5 (−32.7, 30.0) –
Semen volume (ml) 41/221 −1.0 (−18.5, 20.2) 4.5 (−13.6, 26.4) –
Total  count (x106) 41/219 −12.1 (−40.8, 30.5) −1.1 (−32.8, 45.4) –
Motile sperm (%) 18/113 3.8 (−16.4, 28.8) 6.0 (−16.5, 34.5) –
Normal cells (%)d 43/247 −0.40 (−8.4, 8.3) −0.8 (7.7, 10.0) –
DFI  (%) 43/246 −9.0 (−25.4, 10.9) −11.7 (−28.0, 8.2) –
Inuendo
Sperm conc (106/ml) 138/793 −8.0 (−22.4, 9.1) −10.7 (−25.0, 6.2) –
Semen volume (ml) 121/698 −3.2 (−12.4, 7.0) −4.2 (−13.5, 6.2) –
Total  count (x106) 119/693 −3.5 (−21.5, 18.6) 8.0 (−25.6, 13.7) –
Motile sperm (%) 135/740 1.0 (−8.0, 10.9) 1.6 (−7.6, 11.8) –
Normal cells (%)cd 132/775 2.3 (−9.3, 15.4) 2.2 (−9.6, 15.6) –
DFI  (%) 132/734 −0.3 (−12.1, 13.1) 1.7 (−10.0, 14.8) –
 expresses the percentage difference between those who have used non-prescription analgesics compared to those who  have not used it.
Analysis of sperm motility only included samples analysed within one hour of collection, and total sperm count and volume only included samples from individuals reporting
no  spillage.
a All outcomes were adjusted for age (continuous), reproductive diseases (yes/no), abstinence time, days (continuous) and fever during the past three months (yes/no);
sperm  concentration, motile sperm and normal cells were further adjusted for spillage (yes/no).
b Test for interaction between non-prescription analgesics and sub-study in each outcome.
c Further adjusted for study sub-group.
d Normal cells were measured using WHO  year 1992 in the Farmer cohort and WHO  year 1999 in the Inuendo cohort.
Table 4
Male reproductive hormones regressed on use of non-prescription analgesics among men from the Farmer and Inuendo studies.
Cohort Outcome Exposed/N Crude  (95% CI) Adjusted  (95% CI)a Interaction pb
Pooledc
LH 167/890 1.1 (−6.1, 8.7) 0.7 (−6.6, 8.6) 0.90
FSH  167/889 1.4 (−7.6, 11.3) 5.7 (−3.5, 15.8) 0.35
Inhibin B 165/884 −3.8 (−10.9, 3.9) −3.9 (−11.2, 4.0) 0.82
SHBG  167/890 2.8 (−3.8, 9.8) 6.7 (−0.3, 14.1) 0.04
Testosterone 167/890 12.7 (6.0, 19.7) 10.4 (4.0, 17.1) 0.25
Estradiol 167/886 6.4 (−0.8, 14.0) 4.1 (−3.2, 11.9) 0.94
Farmers
LH  40/246 0.1 (−14.1, 16.6) 0.02 (−14.2, 16.6) –
FSH  40/246 −0.8 (−17.6, 19.4) −1.2 (−17.9, 19.0) –
Inhibin B 39/241 −5.9 (−21.6, 12.9) −5.1 (−20.7, 13.6) –
SHBG  40/247 −5.0 (−17.2, 9.0) −5.4 (−17.4, 8.5) –
Testosterone 40/246 3.2 (−7.2, 14.9) 3.7 (−7.0, 15.4) –
Estradiol 40/245 3.3 (−16.4, 27.6) 3.0 (−16.7, 27.3) –
Inuendo
LH  127/644 1.4 (−6.7, 10.2) 1.3 (−7.1, 10.5) –
FSH  127/643 2.1 (−8.4, 13.8) 9.3 (−1.5, 21.3) –
Inhibin B 126/643 −3.1 (−10.7, 5.2) −3.2 (−11.2, 5.5) –
SHBG  127/643 5.5 (−2.2, 13.7) 11.1 (2.9, 20.0) –
Testosterone 127/644 16.0 (7.8, 24.7) 12.3 (4.5, 20.7) –
Estradiol 127/641 7.4 (1.4, 13.7) 4.0 (−1.9, 10.23) –
 expresses the percentage difference between those who have used non-prescription analgesics compared to those who  have not used it.
r after
 outco
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ea Adjusted for age (continuous, years) and time of the day for sampling (before o
b Test for interaction between non-prescription analgesics and sub-study in each
c Crude and adjusted pooled analyses are adjusted for cohort.rom NSAIDs may  e.g. cause an increase in testosterone production
t the gonadal level or through a higher testosterone synthesis but
xperimental studies need to examine the mechanism. 12 a.m.).
me.The present study has some limitations. The participation rate
was low in the original studies (18% in the Lead worker and Inuendo
studies) which could introduce selection bias in both directions. In
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[B.B. Høyer et al. / Reproduc
he Lead worker and Farmer studies, some of the men  had knowl-
dge of their fertility and since men  with reproductive problems
re more likely to participate in semen quality studies [21] this may
ave caused selection bias if more men  with reduced semen quality
nd with higher intake of non-prescription analgesics participated.
e believe, however, that participants hardly payed special atten-
ion to intake of non-prescription analgesics as the original studies
xamined occupational and environmental exposures and did not
ocus on medication.
Information on intake of non-prescription analgesics was self-
eported in questionnaires and we have no information on the dose
nd length of the intake. In addition, the fact that the use of NSAIDs
s reported to be two-fold the use of paracetamol could indicate
nderreporting of paracetamol use. This may  have led to misclas-
iﬁcation of the exposure variables which could attenuate a true
ssociation. Thus, we cannot exclude the possibility that in fact
ntake of non-prescription analgesic is associated with lower semen
uality and studies with more precise exposure information are
arranted.
The cross-sectional nature of our study disables possibilities of
etermining causality between non-prescription analgesic use and
emen quality and sex hormone levels and the possible impact of
reexisting illness. In addition, as we did not have any informa-
ion of indication of use, we cannot eliminate the risk of reverse
ausation since higher testosterone levels may  be associated with
ehaviour that could led to higher intake of non-prescription anal-
esics. In future follow-up studies of the association between intake
f non-prescription analgesics and male reproductive function, it is
f great importance to receive accurate information on indication
f use, medication type as well as dose and length of intake.
Also, it is suggested that exposure during the prenatal period is a
ore crucial window of exposure as the gonads and the reproduc-
ive capacity are developed during fetal life, and a follow-up study
howed a positive association between intake of paracetamol for
ore than four weeks during pregnancy and increased occurrence
f cryptorchidism [22]. Hence, a follow-up study investigating
he association between maternal intake of non-prescription anal-
esics during pregnancy and subsequent reproductive capacity in
oung men  would be of high interest.
Our analysis also has several strengths, such as the large study
opulation and a study population from Greenland and from 7
uropean countries with a large age span and comparable repro-
uctive outcomes. Furthermore, we have data on conventional
arkers of semen quality and reproductive hormones and sev-
ral personal characteristics, the latter enabling us to adjust for
mportant potential confounding factors.
In conclusion, in this cross-sectional analysis, we  found that
ntake of NSAIDs and combination drugs were associated with
lightly higher testosterone levels in healthy Greenlandic and Euro-
ean men. Intake of non-prescription analgesics was  not associated
ith other hormones or with common markers of semen quality.
ossible misclassiﬁcation of data on use of analgesics may  have
ttenuated the results and studies with more precise exposure
nformation are warranted.
uthor’s role
JPB, GT and SBL collected the data. JP, GT, CHRH and BBH con-
ributed to the design, analyses and interpretation of data. BBH
urther was responsible for statistical analyses and writing the draft
ersion of the manuscript. All authors revised the manuscript and
pproved the ﬁnal version for publication.
[xicology 74 (2017) 70–76 75
Funding
This article is part of the ReproUnion collaborative study, co-
ﬁnanced by the European Union, Intereg V ÖKS. The Lead worker
and the Farmer studies were both part of Asclepios—an EU con-
certed action addressing occupational risk to male reproductive
capability 1993–1998. The Inuendo study addressed biopersistent
organochlorines in diet and human fertility 2002–2005 and was
supported by a grant from the European Union (QLK4-CT-2001-
00202). The funding agencies had no role in study design, collection,
analysis, or interpretation of the data.
Conﬂict of interest
The authors have no conﬂicts of interest.
Acknowledgements
We thank the Asclepios group and the Inuendo group for their
work in planning and conducting the original semen quality stud-
ies.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.reprotox.2017.
09.004.
References
[1] S. Juul, W.  Karmaus, J. Olsen, Regional differences in waiting time to
pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy
and Sweden. The european infertility and subfecundity study group, Hum.
Reprod. 14 (5) (1999) 1250–1254.
[2] D.M. Kristensen, et al., Analgesic use—prevalence, biomonitoring and
endocrine and reproductive effects, Nat. Rev. Endocrinol. 12 (7) (2016)
381–393.
[3] S. Stone, M.A. Khamashta, C. Nelson-Piercy, Nonsteroidal anti-inﬂammatory
drugs and reversible female infertility: is there a link? Drug Saf. 25 (8) (2002)
545–551.
[4] C. Gupta, Prostaglandins masculinize the mouse genital tract, Endocrinology
124 (4) (1989) 1781–1787.
[5] A. Ottani, et al., The analgesic activity of paracetamol is prevented by the
blockade of cannabinoid CB1 receptors, Eur. J. Pharmacol. 531 (1–3) (2006)
280–281.
[6] D.M. Kristensen, et al., Intrauterine exposure to mild analgesics is a risk factor
for development of male reproductive disorders in human and rat, Hum.
Reprod. 26 (1) (2011) 235–244.
[7] S. van den Driesche, et al., Prolonged exposure to acetaminophen reduces
testosterone production by the human fetal testis in a xenograft model, Sci.
Transl. Med. 7 (288) (2015) 288ra80.
[8] G. Stutz, et al., The effect of alcohol: tobacco, and aspirin consumption on
seminal quality among healthy young men, Arch. Environ. Health 59 (11)
(2004) 548–552.
[9] A.C. Martini, et al., Analysis of semen from patients chronically treated with
low  or moderate doses of aspirin-like drugs, Fertil. Steril. 80 (1) (2003)
221–222.
10] M.A. Gates, et al., Non steroidal anti-inﬂammatory drug use and levels of
oestrogens and androgens in men, Clin. Endocrinol. (Oxf) 76 (2) (2012)
272–280.
11] J.P. Bonde, et al., Sperm count and chromatin structure in men exposed to
inorganic lead: lowest adverse effect levels, Occup. Environ. Med. 59 (4)
(2002) 234–242.
12] S.B. Larsen, et al., Semen quality and sex hormones among organic and
traditional Danish farmers: ASCLEPIOS study group, Occup. Environ. Med. 56
(2)  (1999) 139–144.
13] G. Toft, et al., Fertility in four regions spanning large contrasts in serum levels
of  widespread persistent organochlorines: a cross-sectional study, Environ.
Health 4 (2005) 26.
14] World Health Organization, WHO  Laboratory Manual for the Examination of
Human Semen and Sperm-cervical Mucus Interaction, WHO, Cambridge,
1992.
15] World Health Organization, WHO  Laboratory Manual for the Examination of
Human Semen and Sperm-Cervical Mucus Interaction, 4th ed., Cambridge
University Press, Cambridge, 1999.
7 tive To
[
[
[
[
[
[
reproductive function by occupational sperm studies: logistics and design
options, Occup. Environ. Med. 53 (8) (1996) 511–519.6 B.B. Høyer et al. / Reproduc
16] A. Rignell-Hydbom, et al., Exposure to PCBs and p,p’-DDE and human sperm
chromatin integrity, Environ. Health Perspect. 113 (2) (2005) 175–179.
17] L. Di Luigi, et al., Do non-steroidal anti-inﬂammatory drugs inﬂuence the
steroid hormone milieu in male athletes? Int. J. Sports Med. 28 (10) (2007)
809–814.
18] S. Mazaud-Guittot, et al., Paracetamol: aspirin, and indomethacin induce
endocrine disturbances in the human fetal testis capable of interfering with
testicular descent, J. Clin. Endocrinol. Metab. 98 (11) (2013) E1757–67.
19] O. Albert, et al., Paracetamol: aspirin and indomethacin display endocrine
disrupting properties in the adult human testis in vitro, Hum. Reprod. 28 (7)
(2013) 1890–1898.
[xicology 74 (2017) 70–76
20] D.M. Kristensen, et al., Paracetamol (acetaminophen): aspirin (acetylsalicylic
acid) and indomethacin are anti-androgenic in the rat foetal testis, Int. J.
Androl. 35 (3) (2012) 377–384.
21] J.P. Bonde, A. Giwercman, E. Ernst, Identifying environmental risk to male22] M.S. Jensen, et al., Maternal use of acetaminophen: ibuprofen, and
acetylsalicylic acid during pregnancy and risk of cryptorchidism,
Epidemiology 21 (6) (2010) 779–785.
